The company provides strong expertise and experience in the design and implementation of Early Clinical Plans, Translational Medicine Scientific Strategy, and in the execution of clinical Phase I and Phase II studies. The critical information collected during these studies, in particular, determines the probability of success for the late stage clinical development.

Website